Chemical Proteomics versus Leishmaniasis  by Ehrmann, Michael et al.
Chemistry & Biology
PreviewsChemical Proteomics versus LeishmaniasisMichael Ehrmann,1 Farnusch Kaschani,2 and Markus Kaiser2,*
1Department of Microbiology, University of Duisburg-Essen, Center for Medical Biotechnology, Faculty of Biology, 45117 Essen, Germany
2Department of Chemical Biology, University of Duisburg-Essen, Center for Medical Biotechnology, Faculty of Biology, 45117 Essen,
Germany
*Correspondence: markus.kaiser@uni-due.de
http://dx.doi.org/10.1016/j.chembiol.2015.03.001
In this issue of Chemistry & Biology, Wright et al. (2015) describe an elegant approach to evaluating sub-
strates and the drug target potential of Leishmania donovani N-myristoyltransferase (NMT) using a techni-
cally simple and straightforward chemical proteomics approach.The identification and validation of novel
drug targets is often the first step in cur-
rent drug discovery (Overington et al.,
2006). Due to the high costs and risks as
well as long development times, potential
drug targets are stringently evaluated
before a new drug discovery campaign
is launched. Economic aspects such as
a favorable intellectual property situation
or promising marketing opportunities
aside, these evaluations naturally also
involve the ‘‘suitability’’ of the drug target,
such as an assessment of its disease rele-
vance or druggability (Gashaw et al.,
2011). Obviously, such investigations
frequently require time, labor, and cost-
intensive molecular, genetic, and phar-
macological studies.
These issues weigh heavily in the devel-
opment of drugs against neglected trop-
ical diseases, a family of biologically
diverse disorders found in poorly devel-
oped tropical or subtropical regions.
Despite an irrefutable unmet medical
need, weak marketing perspectives and
low academic funding rates severely
restrict the discovery of novel chemother-
apeutics against these fatal diseases.
Neglected tropical disease drug develop-
ment is not solely hampered by economic
aspects, however, but also by a lack of
suitable approaches to overcome these
disorders (Nwaka and Hudson, 2006). In
fact, for many neglected tropical dis-
eases, target identification as the starting
point for drug discovery has been and
still is a tedious and challenging task,
because molecular manipulations of the
causing pathogens, disease models for
target assessment, or even a basic under-
standing of the underlying disease mech-
anisms are still limited.
These challenges call for alternative
complementary approaches. In the lastyears, chemical proteomics, an approach
in which small-molecule probes are used
to covalently tag proteins in a function-
dependent manner, has emerged into
just such a complementary technology
for drug-target discovery (Jeffery and
Bogyo, 2003; Cravatt et al., 2008). Amajor
advantage of chemical proteomics is that
once the overall workflow has been
established, the methodology can be
adapted relatively simply and rapidly to
different biological systems. This advan-
tage of chemical proteomics has been
exploited by Wright et al., who used an
in-house established approach for eluci-
dating the global impact of N-myristoyl-
transferase (NMT)-dependent protein
myristoylation (Wright et al., 2015). In their
approach, a combination of an alkyne-
tagged myristic acid analog and chemical
knockdown experiments is used to iden-
tify NMT substrates and to quantify their
relative abundance in diverse biological
systems and processes. These studies
led, for example, to the elucidation of
plasmodial NMT as a potential antima-
larial drug target (Wright et al., 2014) or
enabled the mapping of myristoylation
patterns in cancer cells (Thinon et al.,
2014).
Wright et al. now adapted this
approach to investigate the relevance of
Leishmania donovani NMT for parasital
protein myristoylation (Wright et al.,
2015). L. donovani is the causing path-
ogen of visceral leishmaniasis (VL), the
most fatal manifestation of leishmaniasis,
which results in a systemic infection
causing organ swelling, fever, and anemia
up to organ failure and death. Current
treatment options are limited and alterna-
tive chemotherapeutic approaches are
thus highly desirable. Although previous
molecular and bioinformatics studies sug-Chemistry & Biology 22, March 19, 2015gested that NMT plays an important role
for proper myristoylation and survival of
L. donovani, a deeper understanding of
its overall contribution to proteomemyris-
toylation and thus drug-target potential so
far has not been reached. Wright et al.
(2015) therefore incubated L. donovani
promastigotes or amastigotes with the
alkyne myristic acid analog, resulting in
an alkyne myristate-modified lipidome
(Figure 1). Subsequent affinity capture
of these proteins via copper-catalyzed
cycloaddition (CuAAC) and quantitative
mass spectrometry permitted a quantita-
tive and global view on L. donovanimyris-
toylation. This approach led to a ‘‘high
confidence’’ identification of, overall, 49
myristoylated proteins (including known
myristoylated substrates such as ARL1
or SMP1) in the amastigote and 113 myr-
istoylated proteins in promastigotes.
These are many more myristoylated pro-
teins than predicted by bioinformatics
estimations, indicating that protein myris-
toylation in L. donovani is much more
important than previously anticipated.
The analysis further revealed that, un-
expectedly, 59% of the myristate-modi-
fied proteins in amastigotes and even
78% in promastigotes did not contain an
N-terminal glycine residue. This motif is,
however, supposed to be an essential
motif for NMT-dependent myristoylation,
indicating that besides NMT, further
enzymes may contribute to protein
myristoylation. To better assess the indi-
vidual contribution of NMT, the authors
combined their metabolic labeling in a
second step with a chemical knockdown
approach. To this end, they preincubated
L. donovani amastigotes and promasti-
gotes with two previously characterized,
biochemically equipotent NMT inhibi-
tors that, however, displayed significantlyª2015 Elsevier Ltd All rights reserved 309
Figure 1. Workflow of the Global Target
Identification and Chemical Knockdown
Approach
Two complementary experiments were performed
to assess parasital NMT substrates. For the first
approach, amastigotes and promastigotes were
grown in the presence of YnMyr (alkyne myristic
acid analog) or myr (myristic acid). Subsequently,
labeled proteins were decorated with AzRB (using
CuAAC), affinity purified on NeutrAvidin, and on-
bead digested with trypsin. After LC-MS/MS the
obtained spectra were searched with MaxQuant
using the Andromeda search engine and label
free quantification turned on. Comparison of the
different data set resulted in a total of 49 high-con-
fidence (81 total), YnMyr-modified proteins in
amastigotes and 113 high-confidence (134 total)
proteins in promastigotes. For the second
approach, amastigotes were preincubated for
1 hr with or without the NMT inhibitors and then
labeled for 12 hr with YnMyr. After work up and
mass spectrometry (same as for first approach),
the four data sets were statistically compared, re-
sulting in the identification of 30 proteins whose in-
tensity was significantly reduced in the presence of
the NMT inhibitors. These proteins were classified
true NMT targets/substrates.
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level. Preincubation of L. donovani cul-
tures with both inhibitors led to an efficient
reduction of parasital myristoylation in a
dose-dependent manner that correlated
well with the experimentally determined
EC50 values, thus confirming target
engagement of the compounds in living
parasites. Chemical knockdown in amas-
tigotes in combination with quantitative
proteomics, however, did not lead to a
uniform reduction in protein myristoyla-310 Chemistry & Biology 22, March 19, 2015tion. Instead, only a subset of 30 proteins
(in a high-confidence interval) was less
myristoylated; interestingly, all of the pro-
teins carried an N-terminal glycine resi-
due, indicating that these 30 proteins are
direct NMT substrates. A subsequent
GO term analysis of these 30 proteins
then revealed that 50% of identified pro-
teins are of unknown function, whereas
the other half are involved in highly diverse
biological processes such as signal trans-
duction, transport, or degradation. This
indicates that a small-molecule-mediated
NMT inhibition may have extensive impli-
cations on L. donovani biology.
Although additional experiments are
required to further validate NMT as aª2015 Elsevier Ltd All rights reservedleishmaniasis drug target, e.g., to exclude
potential off-target effects of the NMT
inhibitors that might contribute to the
observed antiparasital effect, the present
study elegantly demonstrates the poten-
tial of chemical proteomics in conjunction
with quantitative mass spectrometry to
rapidly catalog posttranslationally modi-
fied proteins and to evaluate potential
drug targets in various biological systems,
using one common approach. This study
might therefore serve as a blueprint for
similar studies on other enzymes and/or
posttranslational modifications that surely
will be addressed in the future.REFERENCES
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